99514-99-5 Usage
Uses
Used in Pharmaceutical Industry:
5-bromo-3-phenyl Salicylic Acid is used as a pharmaceutical agent for its potential anti-inflammatory and anticoagulant effects. It is being studied for its ability to modulate inflammatory responses and blood clotting processes, which could be beneficial in the treatment of various inflammatory and cardiovascular conditions.
Used in Oncology:
In the field of oncology, 5-bromo-3-phenyl Salicylic Acid is used as a potential anticancer agent. It is being investigated for its ability to target and inhibit the growth of certain types of cancer cells, making it a promising candidate for cancer therapy.
Used in Organic Synthesis:
5-bromo-3-phenyl Salicylic Acid is used as a key intermediate in the synthesis of various organic compounds. Its unique structure and functional groups make it a valuable building block for the development of new pharmaceuticals, agrochemicals, and other specialty chemicals.
Used as a Chemical Reagent:
In the realm of chemical research and development, 5-bromo-3-phenyl Salicylic Acid serves as a reagent in various chemical reactions. Its bromine atom and phenyl group can participate in a range of reactions, such as substitution, addition, and coupling reactions, facilitating the synthesis of complex organic molecules.
Check Digit Verification of cas no
The CAS Registry Mumber 99514-99-5 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 9,9,5,1 and 4 respectively; the second part has 2 digits, 9 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 99514-99:
(7*9)+(6*9)+(5*5)+(4*1)+(3*4)+(2*9)+(1*9)=185
185 % 10 = 5
So 99514-99-5 is a valid CAS Registry Number.
99514-99-5Relevant academic research and scientific papers
Structure-guided design, synthesis, and evaluation of salicylic acid-based inhibitors targeting a selectivity pocket in the active site of human 20α-hydroxysteroid dehydrogenase (AKR1C1)
El-Kabbani, Ossama,Scammells, Peter J.,Gosling, Joshua,Dhagat, Urmi,Endo, Satoshi,Matsunaga, Toshiyuki,Soda, Midori,Hara, Akira
experimental part, p. 3259 - 3264 (2010/06/16)
The first design, synthesis, and evaluation of human 20α- hydroxysteroid dehydrogenase (AKR1C1) inhibitors based on the recently published crystal structure of its ternary complex with inhibitor are reported. While the enzyme-inhibitor interactions observ
